NLRC3 and Alzheimer disease: Our data suggest that APP/PS1 mice displayed AD-like symptoms with impaired learning and memory ability, and this defect can be partially rescued in consistent with the overexpression of NLRC3 in the APP/PS1 + LV-NLRC3 group (Figure 2(c)).